1.
Bull Exp Biol Med
; 159(5): 649-51, 2015 Sep.
Artículo
en Inglés
| MEDLINE
| ID: mdl-26468020
RESUMEN
The number of CD3(+)CD56-HLA-G(+) cells in the peripheral blood of breast cancer patients was shown to increase by 2 times. Our results and published data suggest that the increase in the relative content of CD3(+)CD56-HLA-G(+) cells in the circulating blood in breast cancer contributes to tumor development due to suppression of antitumor immunity.